Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Nanni, Cristina Intitute of Nuclear Medicine, University of Bologna, Italy.
Baum, Richard P. Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Germany.